Extraordinary General Meeting 2018

The shareholders in Oncopeptides AB (publ), reg. no. 556596-6438, (“Oncopeptides” or the “Company”) are hereby given notice to attend the Extraordinary General Meeting to be held at Tändstickspalatset, Västra Trädgårdsgatan 15, Stockholm, Sweden, Wednesday 5 December 2018 at 3:00 p.m.

 

Coffee will be served starting at 2:00 p.m., at which time the registration for attendees will commence.

Upcoming events

Carnegie Healthcare Conference

-

47th Annual Meeting of the EBMT

-

The European Society for Blood and Marrow Transplantation 2021.

AACR Annual Meeting 2021

-

Virtual Meeting Week 1: April 10-15; Week 2: May 17-21

European School of Haematology E-conference 2021

-

E-Conference - How to Diagnose and Treat Multiple Myeloma.

COMy 2021

-

World Congress on Controversies in Multiple Myeloma 2021.

ASCO 2021 Annual Meeting

-

American Society of Clinical Oncology (ASCO) 2021.

EHA 2021 Virtual Congress

-

European Hematology Association Annual meeting 2021.

Interim Report Q2 2021

08:00 CET

Interim Report Q3 2021

08:00 CET